Related Articles
Cox-2 and Her2/neu co-expression in invasive bladder cancer
HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patients
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer
Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor
Bone marrow-derived dendritic cells incorporate and process hydrophobized polysaccharide/oncoprotein complex as antigen presenting cells.